Abstract
INTRODUCTION: Cervical cancer represents a significant public health problem, especially in developing countries. Early detection through organized screening using cytological tests and, more recently, HPV testing has proven fundamental in reducing both incidence and mortality (ASANGBEH- KERMAN et al., 2022). OBJECTIVES: To assess the effectiveness of early cervical cancer screening and its relationship with clinical outcomes and patients’ quality of life. METHODOLOGY: A bibliographic review was conducted from March to June 2025, based on national and international studies published between 2000 and 2025, using the PubMed and SciELO databases, with Health Sciences Descriptors (DeCS): “Uterine Neoplasms” and “Antineoplastic Protocols”. Inclusion criteria were: articles in Portuguese, English, or Spanish; published between 2015 and 2025; and addressing the themes proposed in this study. Exclusion criteria included: duplicate articles, abstracts only, studies not directly related to the topic, or not meeting the other inclusion criteria. The final sample consisted of 9 articles. RESULTS: Regular screening, especially when initiated early and with adequate population coverage, significantly reduced advanced cases of cervical cancer. Integration with HPV vaccination programs (WIRTZ et al., 2022), health education strategies, and primary care services strengthens the effectiveness of screening. However, barriers such as low adherence, regional disparities, and lack of professional training still hinder its full effectiveness (SANTOS et al., 2019). CONCLUSION: Early screening for cervical cancer is a highly effective intervention in reducing the disease burden. Its expansion, quality improvement, and integration with educational actions and consistent public policies are essential.
Keywords: Cervical cancer; Screening; Early detection; HPV; Public health.
References
ALMEIDA, Gutemberg et al. Preventing uterine cervix cancer: The clinical meaning of atypical glandular cells. Revista Brasileira de Ginecologia e Obstetrícia, v. 44, p. 483-488, 2022.
ASANGBEH-KERMAN, Serra Lem et al. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies. BMC Public Health, v. 22, n. 1, p. 1530, 2022.
JHA, Ashish Kumar et al. Systematic review and meta-analysis of prediction models used in cervical cancer. Artificial Intelligence in Medicine, v. 139, p. 102549, 2023.
LIU, Xiaoxia et al. Electronic Health Interventions and Cervical Cancer Screening: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, v. 26, p. e58066, 2024.
ORGANIZACIÓN PANAMERICANA DE LA SALUD. Síntesis de evidencia y recomendaciones: directriz para el tamizaje, la detección y el tratamiento del cáncer de cuello uterino. Revista Panamericana de Salud Pública, v. 47, p. e72, 2023.
PEDRO, Amélia et al. Orientações de Consenso para a Abordagem dos Resultados Alterados nos Testes de Rastreio do Cancro do Colo do Útero pela SPCPTGI. Acta Médica Portuguesa, v. 36, n. 4, p. 285-295, 2023.
SANTOS, Renata Oliveira; RAMOS, Danielle Nogueira; MIGOWSKI, Arn. Barreiras na implementação das diretrizes de detecção precoce dos cânceres de mama e colo do útero no Brasil. Physis: Revista de Saúde Coletiva, v. 29, p. e290402, 2019.
SHPENDI, Sonia et al. Identifying the key barriers, facilitators and factors associated with cervical cancer screening attendance in young women: A systematic review. Women's Health, v. 21, p. 17455057251324309, 2025.
WIRTZ, Charlotte et al. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment: a systematic review. Vaccine, v. 40, p. A116-A123, 2022.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Jainy Marconcini Rohr, Ana Carollina Bellan Oliveira, Maria Victória Lima Merlo , Rafael Barbosa Lesquevez de Souza, Thamiris Scárdua da Costa Galleti